forphenicinol has been researched along with Fibrosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, H; Ishizuka, M; Naito, K; Nakadaira, M; Okura, A; Takeuchi, T; Umezawa, H | 1 |
| Nitta, K; Tanaka, T | 1 |
| Ishizuka, M; Naito, K; Okura, A; Sawazaki, Y; Takeuchi, T; Umezawa, H | 1 |
3 other study(ies) available for forphenicinol and Fibrosarcoma
| Article | Year |
|---|---|
Effect of forphenicinol on the production of lipopolysaccharide-induced interferon and tumor necrosis factor and on the growth of Meth A fibrosarcoma in mice.
Topics: Adjuvants, Immunologic; Animals; BCG Vaccine; Drug Synergism; Female; Fibrosarcoma; Glycine; Glycoproteins; Interferons; Lipopolysaccharides; Mice; Specific Pathogen-Free Organisms; Tumor Necrosis Factor-alpha | 1987 |
[Enhancement of immune response by an antitumor agent, cyclophosphamide].
Topics: Animals; Cell Line; Cyclophosphamide; Female; Fibrosarcoma; Glycine; Immunity, Cellular; Leukemia L1210; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; T-Lymphocytes, Regulatory | 1986 |
Antitumor effect of forphenicinol, a low molecular weight immunomodifier, in combination with surgery on Meth A fibrosarcoma, Lewis lung carcinoma, and adenocarcinoma 755.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Fibrosarcoma; Glycine; Lung Neoplasms; Macrophage Activation; Mice; Mice, Inbred Strains; Neoplasms, Experimental | 1986 |